Hypofractionated radiation therapy for prostate cancer: The McGill University Health Center experience.
DISCUSSION: Our technique changed from 3D to intensity modulated radiotherapy with the dose adjusted to 60Gy in 20 fractions. Lastly, we have expanded the program to high-risk patients where IMRT treatments are given to the pelvic nodes (44Gy in 20 fractions) with a simultaneous integrated boost delivery to the prostate (60Gy in the same 20 fractions). Our long-term results have shown that moderate hypofractionated radiotherapy for prostate cancer is safe and provides good tumor control comparable to high-dose conventionally fractionated radiotherapy. This hypofractionated regimen has been routinely used in our institution.
PMID: 26278988 [PubMed - as supplied by publisher]
Source: Cancer Radiotherapie - Category: Cancer & Oncology Authors: Barbosa Neto O, Souhami L, Faria S Tags: Cancer Radiother Source Type: research
More News: Cancer | Cancer & Oncology | Health | Hormonal Therapy | Hormones | Intensity-Modulated Radiation Therapy | Prostate Cancer | Radiation Therapy | Toxicology